| Company Name: |
Chemsky (shanghai) International Co.,Ltd
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:ThroMboxane A2 PotassiuM Salt;(5Z,9α,11α,13E,15S)-9,11-epoxy-15-HydroxythroMboxa-5,13-dien-1-oic Acid MonopotassiuM Salt; TXA2 PotassiuM Salt; (5Z)-7-[(1S,3R,4S,5S)-3-[(1E,3S)-3-Hydroxy-1-octen-1-yl]-2,6-dioxabicyclo[3.1.1]hept-4-yl]-5-heptenoic Acid PotassiuM Salt
CAS:98509-73-0
Purity:98+% Package:1Mg;5Mg;10Mg;50Mg;100Mg;500Mg
|
| Company Name: |
CLEARSYNTH LABS LTD.
|
| Tel: |
+91-22-45045900 |
| Email: |
sales@clearsynth.com |
| Products Intro: |
Product Name:Thromboxane A2 PotassiumSalt
CAS:98509-73-0
|
| Company Name: |
Toronto Research Chemicals
|
| Tel: |
+1 (416) 665-9696 |
| Email: |
info@trc-canada.com |
| Products Intro: |
CAS:98509-73-0
Package:24000USD/10mg
|
| Company Name: |
ShangHai Anpel Co, Ltd.
|
| Tel: |
021-54890099 |
| Email: |
shanpel@anpel.com.cn |
| Products Intro: |
Product Name:Thromboxane A2 Potassium Salt
CAS:98509-73-0
Package:10mg
|
|
| | ThroMboxane A2 PotassiuM Salt Basic information |
| Product Name: | ThroMboxane A2 PotassiuM Salt | | Synonyms: | ThroMboxane A2 PotassiuM Salt;(5Z)-7-[(1S,3R,4S,5S)-3-[(1E,3S)-3-Hydroxy-1-octen-1-yl]-2,6-dioxabicyclo[3.1.1]hept-4-yl]-5-heptenoic Acid PotassiuM Salt;(5Z,9α,11α,13E,15S)-9,11-epoxy-15-HydroxythroMboxa-5,13-dien-1-oic Acid MonopotassiuM Salt;TXA2 PotassiuM Salt;(Z)-7-[(1S,2S,3R,5S)-3-[(E,3S)-3-hydroxyoct-1-enyl]-4,6-dioxabicyclo[3.1.1]heptan-2-yl]hept-5-enoate | | CAS: | 98509-73-0 | | MF: | C20H33KO5 | | MW: | 392.58 | | EINECS: | | | Product Categories: | Fatty Acid Derivatives & Lipids;Glycerols;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 98509-73-0.mol |  |
| | ThroMboxane A2 PotassiuM Salt Chemical Properties |
| | ThroMboxane A2 PotassiuM Salt Usage And Synthesis |
| Uses | A thromboxane derivative that acts as a potent proaggregatory and vasoconstrictor substance. It stimulates activation of new platelets as well as increases platelet aggregation. TXA2 biosynthesis is persistently enhanced in association with several cardiovascular risk factors, including non-insulin-dependent diabetes mellitus, type IIa hypercholesterolemia, polycythemia vera and homozygous homocystinuria. |
| | ThroMboxane A2 PotassiuM Salt Preparation Products And Raw materials |
|